Position in SRRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$152,345,050
+$60,742,415 QoQ
Shares Held
2,769,910
+33.2% QoQ
Ownership
2.27%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 304 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. SRRK ranks #12 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in SRRK
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,345,050 | 2,769,910 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $91,602,635 | 2,079,515 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $41,628,346 | 1,175,278 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $52,514,517 | 1,633,422 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $86,043,197 | 1,990,819 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $13,858,133 | 1,730,104 | Shares | Sole | 2025-11-12 | |
| 2022-12-31 | $1,376,505 | 152,100 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,180,179 | 170,300 | Shares | Sole | 2023-11-13 | |
| 2022-03-31 | $7,403,655 | 574,372 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $14,267,400 | 574,372 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $11,265,829 | 341,182 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $9,860,159 | 341,182 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $17,284,280 | 341,182 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $30,573,900 | 630,000 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $7,164,450 | 405,000 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $7,375,050 | 405,000 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $4,904,550 | 405,000 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||